Arch Therapeutics, Inc. (ARTH) has 3 open-market insider trades by 3 insiders since 2023. The most active filer is Laurence Hicks, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Laurence Hicks | Dir | — | 1 | $3K | 2023-08-31 |
| Michael S. Abrams | CFO | — | 1 | $3K | 2023-08-31 |
| Terrence W. Norchi | Pres | — | 1 | $2K | 2023-08-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Terrence W. Norchi | President | Buy | $2K | 2023-08-31 |
| Laurence Hicks | Director | Buy | $3K | 2023-08-31 |
Companies that share insiders with ARTH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.